<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2021, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 11 Dec 2019 10:01:42 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Therapeutics (KZIA) Commences Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Kazia+Therapeutics+%28KZIA%29+Commences+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233072.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:01:42 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma</title>
   <link>http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Kazia+Initiates+Preparatory+Activities+to+Bring+GDC-0084+into+GBM+AGILE%2C+an+International+Phase+II++III+Study+in+Glioblastoma/16233036.html</guid>
   <pubDate>Wed, 11 Dec 2019 10:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway</title>
   <link>http://www.streetinsider.com/Press+Releases/St+Jude+Study+of+GDC-0084+in+DIPG+Successfully+Completes+First+Stage%3B+Second+Part+of+Study+Now+Underway/15908979.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/St+Jude+Study+of+GDC-0084+in+DIPG+Successfully+Completes+First+Stage%3B+Second+Part+of+Study+Now+Underway/15908979.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/St+Jude+Study+of+GDC-0084+in+DIPG+Successfully+Completes+First+Stage%3B+Second+Part+of+Study+Now+Underway/15908979.html</guid>
   <pubDate>Thu, 12 Sep 2019 09:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22942899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.23531122</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway</title>
   <link>http://www.streetinsider.com/Press+Releases/St+Jude+Study+of+GDC-0084+in+DIPG+Successfully+Completes+First+Stage%3B+Second+Part+of+Study+Now+Underway/15908979.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/St+Jude+Study+of+GDC-0084+in+DIPG+Successfully+Completes+First+Stage%3B+Second+Part+of+Study+Now+Underway/15908979.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/St+Jude+Study+of+GDC-0084+in+DIPG+Successfully+Completes+First+Stage%3B+Second+Part+of+Study+Now+Underway/15908979.html</guid>
   <pubDate>Thu, 12 Sep 2019 09:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22942899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.23531122</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
  <item>
   <title>St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway</title>
   <link>http://www.streetinsider.com/Press+Releases/St+Jude+Study+of+GDC-0084+in+DIPG+Successfully+Completes+First+Stage%3B+Second+Part+of+Study+Now+Underway/15908979.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/St+Jude+Study+of+GDC-0084+in+DIPG+Successfully+Completes+First+Stage%3B+Second+Part+of+Study+Now+Underway/15908979.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/St+Jude+Study+of+GDC-0084+in+DIPG+Successfully+Completes+First+Stage%3B+Second+Part+of+Study+Now+Underway/15908979.html</guid>
   <pubDate>Thu, 12 Sep 2019 09:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22942899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.23531122</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KZIA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVGNF</category>
   	  </item>
 </channel>
</rss>
